Skip to main content
. 2014 Jan 29;4:3866. doi: 10.1038/srep03866

Table 3. Distribution of selected characteristics of the patient cohort.

  Cases n = 248    
n(%)   TT TC CC χ2 P
Age(year) <60 26(10.5) 37(14.9) 28(11.3) 0.920 0.631
≥60 43(17.3) 73(29.4) 41(16.5)      
sex male 58(23.3) 94(37.9) 59(23.8) 0.079 0.961
female 11(4.4) 16(6.5) 10(4.0)      
Grading well- moderately differentiation 53(21.4) 85(34.3) 51(20.6) 0.283 0.868
poorly differentiation 16(6.5) 25(10.1) 18(7.3)      
T Grade T1–T2 37(5.6) 49(12.5) 20(3.6) 8.820 0.012*
T3–T4 32(12.9) 61(24.6) 49(19.8)      
TNM stage I–II–III 54(21.8) 75(30.2) 40(16.1) 6.543 0.038*
IV 15(6.0) 35(14.1) 29(11.7)      
Location of the tumor Epimere- midportion 41(16.5) 58(23.4) 40(16.1) 1.065 0.587
hypomere 28(11.3) 53(21.4) 29(11.7)      
Length <5 52(21.0) 70(28.2) 35(14.1) 9.025 0.011*
≥5 17(6.9) 40(16.1) 34(13.7)      
Lymphnode metastasis Yes 34(13.7) 65(26.2) 35(14.1) 2.066 0.356
No 35(14.1) 45(18.1) 34(13.7)      
Nerve involvement yes 48(19.4) 77(31.0) 48(19.4) 0.005 0.997
  no 21(8.5) 33(13.3) 21(8.5)    
Cardiac involvement yes 49(19.8) 88(35.5) 53(21.4) 1.913 0.384
no 20(8.1) 22(8.9) 16(6.5)      
Vascular tumor thrombus yes 58(23.4) 85(34.3) 56(22.6) 1.282 0.527
no 11(4.4) 25(10.1) 23(9.3)      

*P < 0.05.